 | Madrigal Pharmaceuticals, Inc. | |||
| NMS : MDGL || Location: United States | ||||
$228.34-4.64 (-1.99%) |
0.25 M | 224.39 - 235.91 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.362 M |
| March 15, 2024 | 3.261 M |
| Feb. 29, 2024 | 3.465 M |
| Feb. 15, 2024 | 3.388 M |
| Jan. 31, 2024 | 3.143 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -5.39 | -5.68 | -5.38% |
| 09/30/2023 | -5.02 | -5.34 | -6.30% |
| 06/30/2023 | -4.67 | -4.69 | -0.37% |
| 03/31/2023 | -5.04 | -4.23 | 16.00% |
| 12/31/2022 | -4.65 | -4.98 | -7.16% |
MDGL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 20.972M | Shares Float | 12.775M |
| Short Float | 3.362M | Market Cap | 4886.06M |
| Institution ownership | 94.65% | Insider ownership | 9.241% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -19.99 | Forward EPS | -14.46 |